Literature DB >> 23265988

Self-reported major depressive symptoms at baseline impact abstinence prognosis in smoking cessation program. A one-year prospective study.

Guillaume Fond1, Sebastien Guillaume, Sylvaine Artero, Paquito Bernard, Grégory Ninot, Philippe Courtet, Xavier Quantin.   

Abstract

OBJECTIVE: The association between major depressive symptoms and smoking has been extensively documented. However, previous studies report conflicting findings about the impact of depression on lapse of smoking cessation. We hypothesize that smokers with self-reported major depressive symptoms at baseline are at higher risk of a lapse.
METHODS: One thousand and twenty participants aged, 18 years and over, were recruited in a smoking-cessation unit. All participants were assessed for their smoking status six times during one year of follow-up. Participants were classified as "euthymic", presenting "minor depressive symptomatology" or "major depressive symptomatology" according to their baseline score on the Hospitalization Anxiety and Depression Scale.
RESULTS: Using Cox's proportional hazard regression modeling, adjusted for potential confounding factors (nicotine dependence, number of cigarettes/day, previous cessation attempt, alcohol misuse, socio-demographic variables), it was shown that lapse is associated with major depressive symptoms (Hazard Ratio: HR=1.23 [1.02;1.47]; p=0.03).
CONCLUSION: Our results suggest the importance for clinicians to deal with depression and to discriminate minor from major depressive symptoms at preliminary smoking cessation consultations.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23265988     DOI: 10.1016/j.jad.2012.11.066

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Positive Psychotherapy for Smoking Cessation: A Pilot Randomized Controlled Trial.

Authors:  Christopher W Kahler; Nichea S Spillane; Anne M Day; Patricia A Cioe; Acacia Parks; Adam M Leventhal; Richard A Brown
Journal:  Nicotine Tob Res       Date:  2015-02-02       Impact factor: 4.244

2.  Medication and aggressiveness in "real world" schizophrenia: current issues and perspectives.

Authors:  Guillaume Fond; Laurent Boyer
Journal:  Psychopharmacology (Berl)       Date:  2016-06       Impact factor: 4.530

3.  Anxiety, depression and smoking status among adults of Mexican heritage on the Texas-Mexico Border.

Authors:  Anna V Wilkinson; Kristina P Vatcheva; Adriana Pérez; Belinda M Reininger; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  Hisp J Behav Sci       Date:  2014-08

4.  To smoke or not to smoke? A qualitative study among young adults.

Authors:  Lionel Pourtau; Elise Martin; Gwenn Menvielle; Fabienne El Khoury-Lesueur; Maria Melchior
Journal:  Prev Med Rep       Date:  2019-06-22

5.  Smoking cessation for improving mental health.

Authors:  Gemma Mj Taylor; Nicola Lindson; Amanda Farley; Andrea Leinberger-Jabari; Katherine Sawyer; Rebecca Te Water Naudé; Annika Theodoulou; Naomi King; Chloe Burke; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2021-03-09

6.  Executive Functions in Tobacco Dependence: Importance of Inhibitory Capacities.

Authors:  Valentin Flaudias; Marie Christine Picot; Jorge Lopez-Castroman; Pierre-Michel Llorca; Audrey Schmitt; Jean Perriot; Vera Georgescu; Philippe Courtet; Xavier Quantin; Sébastien Guillaume
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.